Overview

Levetiracetam Treatment of Tardive Dyskinesia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam